Current Shortage Status
Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets
Medium NHSBSA SSPSandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.
What to Do If You're Affected
- Contact your pharmacy as soon as possible — don't wait until you run out
- Ask your pharmacist if a Serious Shortage Protocol (SSP) is active
- Speak to your GP about prescribing an alternative
- Try other local pharmacies who may have different stock
- Sign up for MediWatch alerts to track this shortage
Frequently Asked Questions
Is Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2. in shortage in the UK in 2026?
Yes — as of 27 March 2026, there is 1 active shortage notification for Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2. in the UK, issued by DHSC or NHSBSA. Sign up for MediWatch alerts to be notified of any changes.
What is Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2. used for?
Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2. is commonly prescribed in the UK for various medical conditions. It is dispensed through NHS pharmacies across the country.
What should I do if I can't get Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2. from my pharmacy?
First, ask your pharmacist if a Serious Shortage Protocol (SSP) is active — this may allow them to dispense an alternative without a new prescription. If not, contact your GP who can prescribe a suitable alternative. Try other local pharmacies as stock levels vary by location.
Page last updated: 27 March 2026. Data checked daily.